Both in Biotechnology
Champions Oncology vs Eloxx Pharmaceuticals
Over the past year CSBR returned −5.3% and ELOX returned −18.0%; their daily moves had a correlation of 0.11.
CSBR −5.3% ELOX −18.0%Growth of $1, one year, split-adjusted
| Metric | CSBR | ELOX |
|---|---|---|
| Price | $4.83 | $12.92 |
| Market cap | $67.2M | $52.2M |
| Today | +0.42% | +0.62% |
| 1 month | −2.8% | −16.2% |
| 6 months | −19.1% | — |
| Year to date | −30.1% | — |
| 1 year | — | — |
| Revenue growth (YoY) | +8.8% | — |
| Gross margin | 50.5% | — |
| Net margin | −2.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.1× | — |
| Net cash | $4.4M | $62.0M |
| Dividend yield | — | — |
| Volatility (60d) | 35.4% | — |
| Short % of float | 1.5% | 1.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).